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Available online 10 October 2018The ESCCAR international congress on Rickettsia and other
intracellular bacteria is a meeting jointly organized by the Amer-
ican Society of Rickettsiology and the European Society of Chla-
mydia, Coxiella, Aanaplasma and Rickettsia (ESCCAR). Noteworthy,
the ﬁrst rickettsial meeting was organized in Smolenice (Slovakia)
already 50 years ago by N. Kordova in 1967 whereas the ﬁrst ESC-
CAR meeting was organized in Marseille (France) in 2008 by Phil-
ippe Brouqui. The 2nd ESCCAR meeting was then held in Heraklion
(Greece) The last ESCCAR meeting took place in Lausanne
(Switzerland) two years ago, from 13th to 16th June 2015. PE
Fournier and G Greub were the president and vice-president of
ESCCAR during last two years and have been the major organizers
of the present Marseille meeting.
The Marseille meeting held during the ﬁrst week of June, was a
great success, with 254 participants from 33 different countries,
originating from all 5 continents. There was a total of 107 oral
presentations including 13 invited talk on Chlamydia or chlamydia-
related bacteria, 11 invited talk on Rickettsia, 22 invited talks on
other intracellular bacteria and 61 oral presentation selected from
abstracts. In addition, 102 posters were presented during three
speciﬁc interactive poster sessions.
1. Scientiﬁc lectures
The ESCCAR-ASR meeting started by Didier Raoult's keynote on
rickettsial major discoveries in the past 3 decades. He nicely
showed that hypothesis-based research is not the only way to* Corresponding author. Institute of Microbiology, University of Lausanne, Bug-
non 48, 1011 Lausanne, Switzerland. Fax: þ(00) 41 21 314 40 60.
E-mail address: gilbert.greub@chuv.ch (G. Greub).
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1286-4579/© 2018 The Authors. Published by Elsevier Masson SAS on behalf of Instit
creativecommons.org/licenses/by-nc-nd/4.0/).broaden our knowledge and that technology-based research that
allows to ﬁsh for new pathogens is also very important, despite
being until recently not recognized by most funding agencies.
Nevertheless, as exempliﬁed by Rickettsia felis culture in frog cell
lines, to recover a new species in culture may rely on hypothesis, i.e.
that an arthropod-associated bacteria likely grows at a lower
temperature (28 C) than mammals associated-rickettsia. R. felis is
also a nice example of genes exchange, this bacterium exhibiting a
very high level of mosaicism, explaining its larger genome as
compared to other rickettsial species. Finally, he showed that in
researchwe have to expect the unexpected. As an example, R. felis is
likely also transmitted by mosquito (and not only by cat ﬂeas) and
may cause in Africa a common skin eruption (called “yaaf”) asso-
ciated with fever and headaches [1].1.1. SESSION 1 and 6 ter: Rickettsia epidemiology
In session 1, Maureen Laroche (France) described the use of
Matrix-Assisted Laser Desorption/Ionization-Time Of Flight mass
spectrometry (MALDI-TOF MS) for arthropod identiﬁcation. Spe-
ciﬁc peptide extraction protocols were developed and a spectrum
database implemented for arthropods. The arthropod legs are
usually used for MALDI-TOF MS identiﬁcation to preserve the rest
of the insect body for culture of bacterial symbionts and DNA
extraction. To date, MALDI-TOF MS is used to efﬁciently identify
hard ticks, cat ﬂeas and mosquitoes. In addition, MALDI-TOF MS
spectra from Rickettsia-infected insects were added to the database,
making this method an efﬁcient, rapid and inexpensive method for
human-biting athropods.
Then, Christopher D. Paddock (USA)made a nice overview of the
currentknowledgeonrickettsioses in theUSA, startingwith thebelief,
at the turn of the third millennium, that only one of these infections,
Rocky Mountain spotted fever (RMSF), was endemic in the country.
However, in the past 15 years, another two rickettsioses were detec-
ted, including those caused by R. parkeri and Rickettsia philipii in the
southeastern, southwestern and western states. In addition, the
epidemiology of RMSF changed, the disease being responsible for
outbreaks in impoverishedpopulationsof southwesternstateswere it
is transmitted by Rhipicephalus sanguineus instead of Dermacentor
ticks in other areas. Dr Paddock highlighted the need to keeput Pasteur. This is an open access article under the CC BY-NC-ND license (http://
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rapidly according to climate and/or demographic changes.
Four short presentations were also part of session 1. Silke
Wolfel (Germany) reported the presence of Rickettsia monacensis in
Ixodes ricinus ticks from northern Denmark. Using multi locus
sequence typing, she detected the bacterium in 4.9% of 367 tested
tick pools and found no difference between German and Danish
strains.Michelle Allerdice (USA) delivered a talk on the prevalence
of R. parkeri in Amblyommamaculatum ticks in southern Arizona. By
studying 182 ticks collected at three locations in national parks, she
detected the bacterium using 23S rRNA and ompA PCRs in 41 ticks.
Depending on locations, the prevalence of the bacterium ranged
from 21 to 40%, thus representing a risk for people visiting national
parks. Then, Dalyte Mordosaite-Busaitiene (Lithuania) reported
the results of a study on rodents in the Curonian Spit, a region of
Lithuania located by the Baltic Sea. On the 238 captured rodents, a
total of 1226 ectoparasites were collected. 16.3%, 7.9% and 43.5% of
ticks, mites and ﬂeas were positive for rickettsiae, respectively. R.
helvetica was detected in ticks, mites and ﬂeas, R. felis in mites and
ﬂeas and R.monacensis in ﬂeas. Other uncharacterized species were
also detected in mites. Finally, Ilaria Pascucci (Italy) detailed the
results of a study aiming at evaluating the diversity of Rickettsia
species in ticks in the Abruzzo and Molise regions of central Italy. A
total of 603 ticks were collected and tested in 178 pools. Using 23S
rRNA, gltA and ompA PCR, they found 93/178 pools (52%) to be
positive. Eight Rickettsia species were identiﬁed, mainly R. slovaca
and R. aeschlimannii, but also R. conorii, R. felis, R. helvetica, R.
massiliae, R. monacensis and R. raoultii.
In SESSION 6 ter, Kevin Macaluso (USA) focused his talk on R.
felis and its transmission by ﬂeas. Then, Emmanouil Angelakis
(France) presented the current knowledge on Rickettsia sibirica
mongolotimonae, which represents one of the more common spe-
cies in France, being more frequent than R. conorii and R. slovacae.
1.2. SESSION 2: updates in the Chlamydiales ﬁeld
The ﬁrst talk of this session was given by Gilbert Greub
(Switzerland) andwas focusing on the biology of chlamydia-related
bacteria. This includes all members of the chlamydiae phylum that
are notmember of the Chlamydiaceae family. It thus encompasses 9
family-level lineages. In his talk, G. Greub speciﬁcally spoke about
the very different intracellular trafﬁc characterizing the different
bacterial species investigated so far, that sometimes includes co-
localization with endoplasmic reticulum markers (Waddlia & Sim-
kania), with Golgi markers (Chlamydia & Estrella) or with markers
of the endocytic pathway (Parachlamydia) [2e4]. This highlights
the huge difference that exists between the different family-level
lineages. G. Greub also summarized current knowledge on chla-
mydial division that appears to rely on RodZ&MreB [5e7]. He then
spoke about persistence and aberrant bodies, as well as new insight
gathered from genomics. Finally, G. Greub summarized the ap-
proaches that may be used to try to identify new T3SS effectors,
which includes (i) using different bioinformatic algorithms trained
with known effectors, (ii) using chaperones as baits to recover the
interacting effectors, and (iii) comparing the composition of the
cytoplasmic fraction of the eukaryotic cell with and without cell
permeabilization with perfringolysin.
In the subsequent talk,Mirja Puollakainen (Finland) highlighted
how the current understanding of chlamydia diversity recently
increased, with a huge biodiversity of chlamydia-related bacteria.
Based on serological studies, she concluded that humans are
commonly exposed toWaddlia and Criblamydia but less commonly to
other chlamydia-related bacteria. This may happen from direct zoo-
notic exposure, sinceanimals includingbats are commonly infected. It
mayalso follow indirect exposure to ticksor interhumantransmissionfollowing respiratory tract infection. Indeed, several hints supports
the role of this bacterial species as an agent of lower respiratory tract
infections, at least in immunocompromised subjects.
Since ticks were recently shown to be infected by different
chlamydia related-bacteria [8], Ludovic Pilloux (Switzerland)
investigatedwhether tick cell lines may be used to grow these strict
intracellular bacteria. He demonstrated the ability of Estrella and
Waddlia to grow in tick cell lines. The subsequent talk, given by
Delaney Burnard (Australia) was about an interesting documen-
tation of Rhabdochlamydiaceae in both ticks and exposed marsu-
pials. This report conﬁrms the occurrence of Rhabdochlamydiaceae
in ticks, previously documented in Switzerland and Algeria [9] and
might provide a ﬁrst hint on tick to mammal transmission of this
family-level lineage, if MLST or genomics demonstrate that clones
from ticks are similar to the strains from mammals. Finally, this
session was concluded by a very nice talk from Manon Vouga
(Switzerland) on the antibiotic susceptibility of Simkania nege-
vensis, a chlamydia-related bacterium of unknown pathogenicity.
1.3. Parallel SESSION 2 bis: pathophysiology of Anaplasmataceae
Jere McBride (USA) ﬁrst described how ehrlichiae subvert
innate host defenses to escape destruction. For this, they possess
tandem repeat effectors (TRPs), major immune-reactive proteins
that interact with a diverse array of host cell targets, notably the
Notch signaling pathway that is activated by TRP120. TRPs stimu-
late phagocytosis in macrophages as well as cytoskeletal reorga-
nization/cell plasticity. The knockdown of TRPs dramatically
inﬂuences ehrlichial infection and survival [10].
Nahed Ismail (USA) pointed out the imbalance between pro-
tective immunity and immunopathology associated to fatal cases of
human monocytic ehrlichiosis. She notably described how an
excess in cytokine and chemokine production results in a patho-
genic response. Virulent Ehrlichia triggers canonical and non-
canonical inﬂammasome activation. In addition, TLRs/MyD88 pro-
mote immunopathology, resulting in enhanced susceptibility to
fatal ehrlichiosis and liver injury [11].
Among short talks, Alejandro Cabezas-cruz (France) described
the accidental discovery of Ehrlichia minasensis, a new species
described in 2016 in Brazil, in Rhipicephalus ticks collected on cattle.
This species is phylogenetically close to E. canis but is pathogenic
for cattle. Then, Tian Luo (USA) also emphasized the role of TRPs in
the pathogenesis of Ehrlichia chaffeensis. TRPs exhibit species-
speciﬁc epitopes and can interact with major cellular processes.
The knock-down of TRPs affects many interacting proteins (Notch
from the cell signaling pathway, vesicle trafﬁcking and intracellular
transport, actin skeleton organization, transcriptional regulation,
metabolism, posttranscriptional modiﬁcation, cell apoptosis),
resulting in 85% of inhibition and 15% of promotion. Further, Sudha
Velayutham (USA) detailed how human anti-Omp1 monoclonal
antibodies inhibit E. chaffeensis infection. Telmo Graca (USA)
explained how the hypervariable region of the outer membrane
protein Msp2 from Anaplasma marginale accepts segments from
various alleles without losing structural coherence across
conserved alleles. Finally, Anne-Claire Lagree (France) described
the role of the Anaplasma phagocytophilum vacuolar membrane
protein in cattle abortion. By studying using VNTR strains from 123
cows including 25 that aborted, she could demonstrate that the
triple-repeat in the APV-A VNTR was a reliable marker of abortion.
1.4. SESSION 3: Bartonella epidemiology
Henri-Jean Boulouis (France) ﬁrst reported a study of 128
Bartonella henselae strains that could be classiﬁed into two geno-
types, 1 or 2, using MLVA. They could also be clustered into two
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strains were from cats only and were non zoonotic strains whereas
genotype B strains were isolated from cats, dogs and humans and
were thus zoonotic strains. Comparison of genomes from group A
and B strains enabled identiﬁcation of few differences including
hypervariable fragments, one of which being an autotransporter
acidic repeat protein. In addition, group B strains have a complete
ARP gene that is expressed whereas group A strains have an
incomplete ARP gene that is not expressed.
Bruno Chomel (USA) detailed the results of a survey of B. hen-
selae infections in an animal shelter in San Francisco, showing a
high prevalence in cats. Pr Chomel then presented data, also
demonstrating a high prevalence of Bartonella infection in selected
bat species. In France, Pipistrella sp. and Myotis sp. are especially
infected by a Bartonella sp. close to B. mayotimonensis. Among
vampire bats from Mexico, 38% of hematophagous, 16% of insec-
tivorous and 4% of frugivorous bats are infected with Bartonella
species [12].
Aranzazu Portillo (Spain) reported the detection of Bartonella
bacteremia in asymptomatic people using an enriched blood cul-
ture system. In 97 asymptomatic patients, a seroprevalence of
82.5% was observed. A total of 20 patients were also culture-
positive, three of whom were seronegative. Three species were
identiﬁed including B. henselae, B. vinsonii subsp. berkhofﬁi and
Bartonella quintana. Richard Hassal (United Kingdom) studied the
inﬂuence of host demography on the genetic diversity of Bartonella
in water voles. Using MLST, Dr HASSAL observed 5 genotypes of B.
grahamii, 5 genotypes of B. taylori and 4 genotypes of B. doshiae.
1.5. Parallel SESSION 3 bis: genomics and genetics of
Chlamydiaceae
In the ﬁrst talk of the genomics session, Adam Polkinghorne
(Australia) nicely summarized the main information gathered on
chlamydia and chlamydia-related bacteria since 1998, when the
ﬁrst Chlamydia genome was sequenced [13]. The number of ge-
nomes then increased exponentially providing a unique opportu-
nity to study in details the evolution of the Chlamydiaceae family,
showing the relatively recent emergence of C. psittaci [14]. He also
discussed the main differences between the different family-level
lineages, underlying the much larger genomes of chlamydia-
related bacteria. In addition to inspiring thoughts on the biology
of Chlamydiales, he also questioned some speciﬁc technological
aspects allowing performing the genomes of these strict intracel-
lular bacteria directly from the clinical samples despite<1% of reads
are of chlamydial origin. Immunomagnetic separation coupled to
multiple displacement ampliﬁcation (MDA), RNA probe hybridiza-
tion and host methylated DNA depletion coupled to MDA are the
tree main approaches used so far. Among others, he underlined the
fact that ﬁsh pathogens exhibit very small genomes alike Chlamy-
diaceae, suggesting that these short genomes may correlates with a
more narrow host range.
The second plenary talk of the session was given by Ian Clarke
(United Kingdom), speciﬁcally focusing on chlamydial plasmids,
which are common among Chlamydiaceae being present in all
species but C. abortus. He initially spoke about the Chlamydia tra-
chomatis plasmid that encodes among other for glycogen, under-
lying that the chlamydia plasmid is increasing the ﬁtness of the
bacteria, as shown by the reduced growth of plasmid-less mutants.
However, plasmid-less strains could also lead to pathogenic in-
fections in mice, showing that ﬁtness does not automatically
correlated to virulence and pathogenicity, since it is only when a
given inoculum is used that signiﬁcant differences start to be seen.
He also underlined how fast the Swedish mutant that lacks the
target of two commercial PCRs spread from 2001 to 2006 inSweden, raising a prevalence of about 60%. He ﬁnally provided
some hints on how to transform chlamydia using the C. trachomatis
plasmid, by underlying that Pgps 2, 3 and 4 (CDS 4, 5 & 6) are not
essential for transformation and rather represent virulence factors.
Then, Kenneth Fields (USA) summarized key steps in chla-
mydial transformation. It started in 2011 with the successful C.
trachomatis transformationwith a plasmid by Clarke s' team [15]. In
parallel, the work by Valdivia et al. [16] was also very important to
obtain quite a number of chemically-induced mutants that were
then phenotypically characterized (forward genetics). Then, by
insertion of “TargeTron” Johnson et al. could obtain some knock-
down [17]. More recently, K. Fields laboratory succeed in targeted
mutagenesis by using the FRAEM technology. FRAEM stands for
ﬂuorescence-reported allelic exchange mutagenesis [18]. This
technology mainly relies on a suicide m-Cherry reporter. Thus,
when allelic exchange occurs, the colour changed from red to green,
with initial transformants being both green & red, thus allowing
easy screen of successful exchanges.
Finally, in the last talk of the meeting, Trestan Pillonel
(Switzerland)nicelypresentedhisdataon the comparative analysis of
Chlamydiales genomes that enables to have new insights in chla-
mydial biology, using a new pan-Chlamydiales genomes database. As
an example, he speciﬁcally discussed about the prediction of
proteineprotein interactions, by looking at syntenic blocks of genes,
andhe identiﬁed somegenes that are likely implicated in the function
of the T3SS, despite being still annotated as hypothetical proteins.
1.6. SESSION 4: pathogenesis of Chlamydia and Chlamydia-
related bacteria
The ﬁrst talk of this session, given by Loyd Vaughan
(Switzerland), described the common occurrence of epitheliocystis
disease in ﬁsh. This infection due to various chlamydia-related
bacteria such as Piscichlamydia and Clavochlamydia is character-
ized by cysts occurring in ﬁsh gills [19]. However, such cysts may
also occur on the ﬁns and skin of ﬁsh, and may be due to various
pathogens including a novel symbiotic gamma-proteobacteria. To
further precise the pathogenesis of chlamydiae in ﬁsh, L Vaughan
developed a zebraﬁsh model of infection [20]; in that model he
convincingly demonstrated that Waddlia may replicates, attracting
mitochondria around the waddlial inclusions, as expected from
livingWaddlia bacteria. More important, in that model, neutrophils
were attracted nearby to the locus of infection.
Allen W. Tsang (USA) then discussed about the possibility to
block chlamydial infection by manipulating the EGFR receptor [21].
Indeed, Chlamydia induces ROS through EGFR. Sulforaphane and
broccoli extracts are well known anti-oxydants but they have a
paradoxical effect by activating the replication of chlamydiae.
Conversely spilanthol, another anti-oxydant, has a very good
inhibitory effect on chlamydiae, reducing the IC50 down to 41
micromol. The effect of spilanthol is likely mediated by its effect on
actin reorganization.
Then, in an inspiring talk, Raphael Valdivia (USA) nicely pre-
sented two key important C. trachomatis virulence factors: Tepp
and Cpos. Tepp is a translocated early phosphoprotein that medi-
ates major changes to the host cell posphoproteome [22]. Cpos is a
chlamydial promoter of cell survival as demonstrated using Cpos
deﬁcient mutants that are defective for growth in A2EN cells and
for survival in mice. This phenotype was associated by the induc-
tion of a Sting-mediated robust type I and type III interferon
response [23].
The session ended by two short talks. First, Nick Wheelhouse
(United Kingdom) presented the data gathered in a cow model of
infection by Waddlia chondrophila. No abortion occurred in the 11
inoculated cows. However, a severe chorioamnionitis was
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suggesting thatWaddliamay disseminate through the bloodstream
infection, before causing a focal placental infection. Indeed,
placenta examination of that case showed a huge replication of
Waddlia and a severe diffuse local inﬂammatory inﬁltrate. In the
ﬁnal talk of the session, Nicolas Jacquier (Switzerland) presented
recent data on the likely role of a homolog of a Bacillus subtilis
sporulation protein in chlamydial division.
1.7. SESSION 5: other fastidious pathogens
Session 5 was dedicated to other zoonotic pathogens. First, Max
Maurin (France) summarized the most recent information on tula-
remia in France. After describing the clinical forms caused by Fran-
cisella tularensis, he detailed its epidemiology, pointing out that in the
USA the bacterium exhibits two distinct cycles, onemountainous and
the second aquatic. Two genotypes co-exist in the USA, types A and B,
like in Slovakia. In contrast, In Europe, Asia, Australia and Africa, only
type B can be found. In the USA, the severity of tularemia varies
greatly according to the causing type, with lethality rates ranging
from 0% (A2), 7% (B) to 28% (A1). Pr Maurin also exposed the reser-
voirs and vectors of F. tularensis, including rodents, cats, ticks and
mosquitoes (Sweden), and highlighted the cases of transmission
through contaminated water ingestion or inhalation (Kosovo), sug-
gesting a role for amoebae, or contact with soil.
Seemay Chou (USA) gave a very nice talk on the interactions of
bacterial symbionts and their tick vectors. Various factors play a
role in interactions between bacteria, including quorum sensing,
contact-dependent, type IV secretion system and peptidoglycan
that provides structural support for the cells. Bacteria possess a
Tae1 cell wall amidase that cuts peptidoglycan and kills cells. Dr
Chou identiﬁed Tae homologs in tick genomes, acquired from
bacteria by lateral gene transfer (LGT). These tick Tae encoding
genes can be classiﬁed into 3 or 4 families and were acquired
through 6 independent LGT events. Tae genes in eukaryotes are
functional and encode for amidases that may be regarded as
domesticated toxins that play a role in host antibacterial defense
[24]. In ticks, Tae proteins may help controlling the bacterial pop-
ulation but the exact mechanism of this control is uncertain and
may involve direct toxicity and/or immunodulation.
Then, Alejandro Cabezas-Cruz (France) described the complex
microﬂora of arthropods, a notion overlooked by PCR. Co-infection
in ticks is common and may inﬂuence the virulence of some of the
pathogens. As an example, Dr Cabezas-Cruz described an anti-
freeze protein that is produced by ticks under the stimulation of
A. phagocytophilum and reverts the virulence of Staphylococcus
aureus. Using a network analysis, 14,000 interactions were identi-
ﬁed among bacteria within I. ricinus ticks, thus highlighting the
importance and complexity of arthropod microbiota. Network
building also enabled the study of abiotic factors on the composi-
tion of the tick pathobiome, notably showing that the environment
plays a role on the relative importance of bacterial populations [25].
Florian Tagini (Switzerland) delivered a short talk on the
pangenome of Mycobacterium kansasii. He compared type I
(virulent) to type II (opportunistic) and type III (avirulent) strains.
Type III strains exhibit a less conserved genome than type I
strains. Type VII secretion system was identiﬁed as associated to
virulence, together with a pathogenicity island containing paral-
ogs of the espA gene. Lesley Bell-Sakyi (United Kingdom) then
reported her experience with the establishment of new tick cell
lines. She has developed and is the curator of the tick cell biobank
at the University of Liverpool that contains 49 cell lines from
ixodid and 5 cell lines from argasid ticks. Dr Bell-Sakyi described
the long and difﬁcult process of establishing a new cell line, a
process that may take up to 7 years.1.8. SESSION 6: pathophysiology of Q fever
Stacey D. Gilk (USA) described the sensitivity of Coxiella burnetii
to host cholesterol levels. She also detailed the role of cholesterol in
the dynamics of the phagolysosomemembranes of macrophages. C.
burnetii-infected phagolysosomes are poor in cholesterol. There-
fore, increasing the phagolysosome concentration in cholesterol
inhibits Coxiella growth. Pr GILK also demonstrated how blocking
acidiﬁcation rescues C. burnetii death. Therefore, cholesterol-
altering drugs kill C. burnetii in a pH-dependent manner [26].
Daniel E. Voth (USA) detailed the complex intra-cellular traf-
ﬁcking of C. burnetii. Using an ex vivo human lung tissue model
(precision cut lung slice system), Pr Voth demonstrated that type IV
secretion system activity is required for phagolysosome fusionwith
autophagosomes. He also described how this ex vivo model helped
to study the role of p62 that localizes in the phagolysosome in a
T4SS-dependent manner and that is stabilized by C. burnetii. He
could conclude that p62 is not required for the intracellular growth
of C. burnetii.
Anne F.M. Janssen (The Netherlands) investigated differentially
expressed genes in patients infected by C. burnetii and having
chronic Q fever. Her objective was to identify new biomarkers for
the diagnosis of Q fever. Dr Janssen identiﬁed the CXCL9 chemokine
as hyperproduced in chronic Q fever. A representative of the De-
fense Science and Technology Laboratory (United Kingdom) then
presented an aerosol model of acute Q fever in the common
marmoset, an animal exhibiting a 99.6% genetic similarity to
humans. Ruud P.H. Raijmakers (The Netherlands) concluded ses-
sion 6 by reporting the case of a 73-y-o patient who presented with
an unusually severe form of chronic Q fever with aneurysm infec-
tion. The patient had antinuclear antibodies and a type 2 cry-
oglobulinemia. Despite treatment with doxycycline and
hydroxychloroquine, the patient's status worsened and he was
successively administered ciproﬂoxacin, mycophenolic acid and
prednisone. However, he developed myopathy, which required the
discontinuation of antibiotics, and died.
1.9. Parallel SESSION 6 bis: type III secretion system of
Chlamydiae
Agathe Subtil (France) presented current knowledge on the
type three secretion system of chlamydiae. She underlined the high
conservation of the secretion apparatus in the differentmembers of
the Chlamydiales order that contrasts with the species speciﬁcity of
the secreted effectors proteins. A Subtil also underlined that a given
chaperone may be used for several effectors and that a given
effector may have more than one effect. Furthermore, the presence
of more than 50 different effectors underline the importance of the
T3SS in controlling the interaction of Chlamydia with its host cell,
these effectors being either (i) implicated in the bacterial entry and
are then already expressed by elementary bodies, before cell
infection or (ii) implicated in tight control of the intracellular trafﬁc
and/or in reducing host response to chlamydial infection. Then,
Carole Kebbi (Switzerland) summarized current knowledge on the
type III secretion system of waddlia, before describing a new
effector called Wace1 and its chaperone. As many as 53 putative
new Waddlia effectors have been identiﬁed and some of them are
currently in the process of being characterized.
1.10. SESSION 7: genomics, transcriptomics and ecology of
Anaplasmataceae
The ﬁrst talk of the Anaplasma sessionwas given by John Steven
Dumler (USA), who speciﬁcally discussed the complex interactions
between A. phagocytophylum and neutrophils, which have opposed
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and cell corruption of neutrophils is achieved thank to the Ana-
plasma protein AnkA, which contains ankyrin repeats. AnkA was
shown to be speciﬁcally secreted by the type IV secretion system of
Anaplasma before locating in the host cell nucleus were it alters
gene transcription by remodeling the chromatin and by modifying
the eukaryote host histone H3 [27]. JS Dumler nicely showed that
AnkA is binding speciﬁc sites of the human genomes that largely
overlap with regions coding for genes that are upregulated. More
important, the proteins implicated in apoptosis control and cyto-
kines were also more expressed as demonstrated by proteomic
analysis. Thus, AnkA appear to be a critical T4SS effector reprog-
ramming neutrophils that improve intracellular growth of Ana-
plasma and its microbial ﬁtness.
Then, Yasuko Rikihisha (USA) presented the importance of the
T4SS of Ehrlichia chaffeensis. Among others, Etf-1 is an effector that
induces the formation of autophagosomes, in a Rab5-dependent
manner [28].
In a very dynamic and inspiring talk, Kelly Brayton (USA) pre-
sented data on the hypothesis that rickettsial exclusion from ticks
might occur due to the presence of an endosymbiont. Practically,
they studied the microbiota of ticks with and without antibiotic
treatment, to cure ticks for the presence of possible symbionts.
Interestingly, the proportion of R. bellii increased when ticks where
treated with antibiotics and the rate of Anaplasma acquisition by
ticks decreased in the presence of increasing amount of R. bellii.
This session was then followed by 5 short talks. First, Chris-
tophe Noroy (Guadeloupe) then presented a bioinformatic algo-
rithm allowing detecting novel T4SS effectors in A.
phagocytophilum. These effectors generally exhibit a high GC con-
tent and are present in genomes regions exhibiting a low coding
density, suggesting recent acquisition by horizontal transfer.
Among 244 putative predicted effectors, several effectors exhibited
ankyrin domains, likely implicated in cell component manipula-
tion. Then, Mustapha Dahmani (France) presented a strategy
allowing detection of Anaplasmataceae using a real-time PCR tar-
geting te 23S rRNA for screening coupled to genus speciﬁc rpoB &
groEL PCR to conﬁrm positive results. This approach allowed
detecting several novel species lineages. Mathilde Gondard
(Guadeloupe) presented a large study on 542 ticks from Caribbean
area demonstrated the high throughput application of their mo-
lecular tools to detect rickettsia and other tick-borne pathogens.
The two last talks of the sessionwere presented by Young-Sun Cho
(Korea) and Jeong-Byoung Chae (Korea) and described the results
of their investigations of various tick-borne pathogens (Anaplasma,
Bartonella and Borrelia) in raccoon dogs and wild boars,
respectively.
1.11. SESSION 8: pathophysiology of Chlamydia
Johannes Heggemann (Germany) ﬁrst discussed of OmcB,
which is a major chlamydial adhesin. Noteworthy, chlamydial entry
may be reduced in presence of anti-OmcB neutralizing antibodies
[29]. Then, he presented the role as adhesins of Pmp21 [30] and
other related polymorphic membrane proteins (Pmps). Interest-
ingly, these Pmps may form hetero-oligomers, allowing a total of
about 1044 combinations. Such high variability of hetero-oligomers
may have been selected upon evolution to have a variety of effec-
tive adhesins that may escape immune response.
The inﬂammasome activation generally induces pyroptosis and
the proteolytic maturation of some pro-inﬂammatory cytokines
such as IL1beta and IL-18. Steven Webster (United Kingdom)
demonstrated that STING and type I IFN are critical for inﬂamma-
some activation after chlamydial infection and this occurs by acti-
vating both the canonical and the non-canonical pathway [31]. Thismay be important by potentially participating in the chlamydial
immunopathogenesis.
Richard Hayward (United Kingdom) convincingly showed the
polymerization of chlamydial cells that typically express the T3SS at
one pole of the coccoid bacteria while the nucleoid is located at the
opposite side of the chlamydial cell. Using modern electron mi-
croscopy tools, he could also show the precise ultrastructure of the
T3SS and its change when activated upon contact of the inclusion
membrane. Richard Hayward also showed how chlamydial entry
may be studied by using both confocal microscopy and electron
microscopy, especially when coupling such ultrastructure in-
vestigations to use of speciﬁc Rac and Arp 2,3 inhibitors [32].
The session also included three short talks. First, Denys Pogor-
yelov (Germany) showed some hints supporting the use of the V-A
ATPase of chlamydia as a drug target. Then, Marie de Barsy
(Switzerland) described an innovative approach that allowed to
detect several new transcriptional regulators in Waddlia, including
two that appeared to likely act on the same genes and one that
likely represent a new sigma factor. Finally, Firuza Bayramova
(Switzerland) showed her work on the division of Waddlia and
reported three new proteins that she identiﬁed to interact with
RodZ, to be recruited at bacterial septum and likely implicated in
the Waddlia division.
1.12. Parallel SESSION 8 bis: Epidemiology and pathophysiology of
ehrlichiae
Session 8bis, dedicated to Anaplasmataceae, started with a talk
by Jean-Lou Marie (France), who made a comprehensive review of
the epidemiology of infections caused by Anaplasmataceae in ani-
mals and humans worldwide. He notably emphasized the impor-
tance of A. marginale infections in cattle, causing a great economic
loss in the USA. He also underlined the complex epidemiological
cycles of these arthropod-borne and zoonotic microorganisms. In
addition, Dr Marie described exhaustively the tick vectors trans-
mitting Anaplasmataceae, showing the strong correlation between
the geographic distributions of tick vectors and the ehrlichioses
that they transmit. Finally, Dr Marie insisted on Candidatus Neo-
ehrichia mikurensis, an emerging, but as-yet uncultured pathogen
distributed in several northern European countries that opened
discussion on this agent and was followed by two other dedicated
talks.
Then, Janet E. Foley (USA) gave a talk on the ecology of Ana-
plasma phogocytophilum, starting with the vectors this species
worldwide and its genetic diversity, describing the various gene
targets used. In the far-eastern USA, Ixodes scapularis and rodents
are the main vector and reservoir, respectively. Interestingly,
northeast virulent strains lack the drhm gene. In the western USA,
Ixodes paciﬁcus is the main vector and its reservoirs are squirrels,
chipmunks, and less commonly bears or deer. In Europe, the
epidemiology is more complicated, with at least 3 tick species and
many reservoirs involved. Pr Foley also made the hypothesis that A.
phagocytophilum and A. marginale derive from a common ancestor
associated to ungulates in the old World.
Further, Jose A. Oteo (Spain) focused his presentation on Can-
didatusNeoehrichia mikurensis, reminding the audience of the ﬁrst
detection of this species in rodents in Japan in 2004 as well as the
role of I. ricinus as its main vector. To date, Candidatus Neoehrichia
mikurensis has been detected in ticks in 20 European countries, in
some instances in co-infection with Borrelia species. The reservoirs
include at least 7 rodent species, mostly Apodemus andMicrotus sp.
mice. Other animals have also been found infected, including dogs.
Pr Oteo described 16 human cases of Candidatus Neoehrichia
mikurensis infection in Europe to date, summarizing their clinical
presentation. He also reported cases of asymptomatic human
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toms. Finally, Pr Oteo explained the difﬁcult laboratory diagnosis of
this infection, relying on PCR due to the absence of a serology assay.
Among short talks, Anna Moniuszko-Malinowska (Poland)
described her experience in the diagnosis of Candidatus Neo-
ehrichia mikurensis human infections in Poland among 665 tick-
bitten patients. The bacterium was only detected by PCR in 3 pa-
tients hospitalized with a meningitis-like syndrome. However, Dr
Moniuszko-Malinowska demonstrated that all three patients had
co-infections, with either A. phagocytophilum or Babesia microti,
and unfortunately, sequencing only conﬁrmed A. phagocytophilum
and E. equi infections. Norio Ohashi (Japan) presented the epide-
miological characteristics of A. phagocytophilum in Japan. He
described the results of a molecular survey in 743 ticks. The bac-
terium was detected in 3.4% of ticks from 6 species. Pr Ohashi
dedicated the second part of his talk to the results of a sero-survey
in Japanese patients, ﬁnding four seropositive patients and
emphasizing the difﬁculty to prepare a valid antigen to obtain
interpretable and reproducible data. The last presentation by Jun-
Gu Kang (Korea) summarized nicely the diagnostic methods for the
detection of tick-borne pathogens in dogs from South Korea. He
ﬁrst described the emergence of the virus causing severe fever with
thrombocytopenia (SFTS), and insisted on the diagnostic difﬁculties
to distinguish this infection from anaplamosis. Then, he brieﬂy
detailed the diagnostic tools used (nested-PCR for tick-borne bac-
teria and RT-PCR and serology for SFTS).
1.13. SESSION 9: New aspects of Q fever
This session started by two invited lectures on the clinical pre-
sentation of Q fever. First, Chantal Bleekers (The Netherlands)
discussed lessons from the large Q fever outbreak that occurred in
the Netherlands and the importance of FDG-PET CT in the follow-
up of subjects with chronic Q fever infection [33]. Then, Mathieu
Million (France) summarized his own clinical experience of this
important infection, which may also be associated with lymphoma
[34].
The remaining talks presented during that Coxiella session were
selected from abstracts. Sonja van Roeden (The Netherlands)
presented the observed long-term complications of chronic Q fever
that included among others aortic aneurysm, valve lesions and
abscesses. Donatoa Raele (Italy) then presented his data on the
presence of Coxiella and Bartonella in red-mites and hypothesized
that the presence of these bacteria in red-mites may be implicated
in the pathogenesis of red-mites associated dermatitis. Raquel
Alvarez-Alonso (Spain) then showed her data on the evolution of
air & environmental Coxiella contamination of a sheep ﬂock during
lambing season. Finally, Hendrik-Jan Roest (The Netherlands)
presented his data obtained in an experimental model of goat
infection.
1.14. Parallel SESSION 9 bis: epidemiology and diagnosis of
Rickettsioses
In the ﬁrst talk, Idir Bitam (Algeria) proposed a review of the
state-of-the-art methods available to trap rodents in their burrows
and collect their ectoparasites in Algeria. Then, he described the
various ﬂea-borne Rickettsia species prevalent in North Africa,
including R. felis and R. typhi, the tick-borne R. conorii, R. aes-
chlimannii, R. massiliae, R. africae, R. slovaca, R. monacensis, R. hel-
vetica, R. rhipicephali, R. sibirica subsp. mongolitimonae, the mite-
borne R. akari and louse-borne R. prowazekii. Pr BITAM also
emphasized the difﬁculty to survey these diseases continuously
due to the limited funding.In the next presentation, Shuji Ando (Japan) summarized the
current knowledge on rickettsial diseases in Japan, highlighting the
major role of scrub typhus and Japanese spotted fever. He also
detailed the case of patient returning from India with infection by a
new species closely related to R. honei and Candidatus R. Kellyi
which they provisionally named « R. indica ». Pr ANDO then re-
ported the results of a genome-based SNP study aiming at geno-
typing R. japonica isolates. Only three genotypes were identiﬁed,
most isolates belonging to genotype I. The hypothesis for this
imbalance among R. japonica genotypes is that genotype I recently
emerged.
In the ﬁve short presentation of session 9bis, John A.J. Prakash
(India) described severe forms of scrub typhus in India as well as a
new ELISA assay that was assessed by comparison with PCR from
blood. The presented study included 54 scrub typhus cases. IgM
ELISA was positive in 83% of cases as compared to 42% for PCR. IgM
ELISA was positive from the 7th day of onset. In contrast, PCR from
blood was negative after 8 days. Therefore, Dr Prakash proposed
that PCR from blood should be reserved to early-phase specimens,
in the ﬁrst seven days after onset, while ELISA should be preferred
after this initial period. Adama Zan Diarra [24] described the use of
MALDI-TOF MS for the identiﬁcation of ticks and tick-associated
bacteria in Mali. In this country, the only known Rickettsia species
are R. africae and R. aeschlimannii. In his study, Dr DIARRA also
detected R. sibirica subsp. mongolitimonae. Ida Chung (USA)
described drawbacks of the various additives to blood for rickettsial
detection. Then, she proposed a new system to preserve R. rickettsii
in blood specimens based on the addition of ACD-A to sampling
tubes, compared to EDTA and heparin. ACD-A exhibited the longest
duration of viability but heparin showed the amount of detectable
DNA over time. Then, Matthew T. Robinson (United Kingdom)
made a comprehensive analysis of the factors affecting the isolation
of rickettsiae from clinical specimens, based on a series of 3227
specimens obtained from 3201 patients in Thailand. The most
commonly isolated species was Orientia tsutsugamushi. The patient
age, duration of fever, duration of illness, presence of a rash,
elevated antibody titers, positive PCR, type of specimen (buffy coat),
individual skills of technicians and time between sampling and
inoculation inﬂuenced levels of isolation. However, a multivariate
analysis only identiﬁed fever >4 days and presence of a rash as
individually affecting the recovery rate. In the ﬁnal presentation of
session 9bis, Cecilia Kato (USA) proposed methods to increase PCR
sensitivity for Rickettsia sp. to 9 copies per reaction using reverse
transcriptase real-time PCR targeting the ribosomal RNA from total
nucleic acids. This assay exhibited in average a 100 higher
sensitivity (5e8 Cts) when compared to regular PCR.1.15. SESSION 10: Rickettsia, from genomics to diagnostics
The ﬁrst speaker of session 10 was Pierre-Edouard Fournier
(France) who reviewed the progresses permitted by genome
sequencing since 2000 in understanding rickettsial pathophysi-
ology. He also described the results of genomic comparisons that
led to the hypothesis that virulence in Rickettsia species is associ-
ated to progressive genome reduction over time, both in terms of
decrease in chromosome size and plasmid size and number [35]. He
ﬁnally unveiled the preliminary results of an ongoing pangenomic
study of Rickettsia species based on the comparison of 79 genomes.
Then, Stanislav Shpynov (Russia) proposed a new multi-
parametric approach for the systematics of rickettsiae based on
their genome sequences. He named this approach genomosyste-
matics. Using a comparison of 49 genomes of Rickettsia species and
O. tsutsugamushi, Pr Shpynov could classify Rickettsia species into 5
groups. He did refute the creation of the transitional group by
P.-E. Fournier et al. / Microbes and Infection 20 (2018) 392e400398removing R. akari and R. australis from this group. O. tsutsugamushi
was the only member of its group. The classiﬁcation system pro-
posed by Pr Shpynov accommodates not only genomic data but also
epidemiological and clinical characteristics.
In the following talk, Marina Eremeeva (USA) made a nice
overview of the ecology, pathogenesis and genetics of R. philipii. She
ﬁrst reminded the audience the story of the discovery of this spe-
cies initially isolated from Californian ticks as strain 364D. Then,
she described accurately the currently known geographic distri-
bution and prevalence of R. philipii, prior to reporting the clinical
symptoms of human infection [36]. This Rickettsia species causes a
febrile illness associated to an inoculation eschar (multiple in 36%
of cases). The infectionwas severe in 29% of cases. Pr Eremeeva also
highlighted the difﬁcult serological diagnosis of R. philipii infections
due to a unique serotype that prevents cross-reactions with other
closely related species.
Among short talks, Kazuhiro Itoh (Japan) summarized the
current knowledge on the antibiotic treatment of Japanese spotted
fever. Factors of good prognosis included a reduced delay between
onset of symptoms and therapy, prolonged duration of antibiotics
and use of a combination of antibiotics rather than monotherapy.
Then, Rong Fang (USA) then reported her ﬁndings on the survival
of R. australis in macrophages being supported by inhibition of IL-
1b secretion. She notably emphasized the role of Atg5, a protein
involved in autophagy, showing that R. australis stimulates Atg5-
induced autophagosomes. Isaura Simoes (USA) summarized the
factors involved in the interaction between SFG rickettsiae and
macrophages. In particular, she observed that rickettsial species
vary in their tropism for macrophages, a phenomenon that she
assumed might be linked to virulence. Then, she described the
tyrosine kinases that play a role in cell invasion. NHE and Pak1 have
a key role in cell invasion by R. conorii but not R. montanensis.
Monika Danchenko (Slovakia) described a rare R. felis isolate ob-
tained from a tick in Slovakia. This isolate was established in cell
culture and precisely genetically characterized. The ﬁnal presen-
tation of session 10 was given by Allen L. Richards (USA) who
described three new mosquito-borne rickettsial isolates from the
Republic of Korea. This study was based on a collection of 2248
mosquitoes. Seven mosquito pools were PCR-positive for rickett-
siae. Two of these rickettsial genotypes are closely related to R. bellii
whereas the phylogenetic position of the third one is less clear,
being either close to R. asembonensis or R. felis.
1.16. SESSION 11: Bartonella pathophysiology
Jane E. Koehler (USA) was the ﬁrst speaker in session 11. She
described the general stress response (GSR) that enables B. quin-
tana to adapt to the changing environments that are the human
bloodstream and the human body louse gut. The GSR, activated
under 28 C, is under the control of PhyR, an antieanti-sigma factor
and RpoE, a sigma factor that is itself under the control of NepR, an
anti-sigma factor. By solving the crystal structure of the PhyR-NepR
complex, Pr Koehler could demonstrate that PhyR undergoes a
dramatic conformational change after phosphorylation and that
this change played a critical role in the adaptative response of B.
quintana to low temperatures.
Diana G. Scorpio (USA) delivered the second talk, about the
putative risk of transfusion-associated Bartonella infections. She
stressed out the fact that there is neither any current testing of
blood products for Bartonella species nor any recommendation on
the assays that may be used for testing. The risk is clearly under-
estimated as demonstrated by a Brazilian study showing a preva-
lence of 3.2% of stored blood specimens infected by B. henselae or B.
clarridgeiae. This elevated rate may reﬂect the frequency of
asymptomatic bacteremia in contact with cats.Then, Oleg Mediannikov (France) summarized his experience
on the detection of Bartonella infections in West Africa. He ﬁrst
detected ﬁve Bartonella species in arthropods, including the new
species B.massiliensis and B. senegalensis in soft ticks and B. raoultii,
B. mastomydis, a B. elizabethae-like species and B. saheliensis in
rodents. Then, by testing patients with unexplained fever in
Senegal, he detected B. quintana in blood in 1% of patients, and
proposed that this bacterium may be transmitted among humans
by head lice and not body lice.
Two short presentations were made in this session, including
that of Algimantas Paulauskas (Lithuania) on the detection of
Bartonella species in 22.4% of wild cervids and 83% of deer keds in
southern Norway. Prof Paulauskas identiﬁed B. schoenbuchensis in
red deer and their keds, and B. bovis in moose. Then, David A. Jaffe
reported the seroprevalence of B. henselae in 32.3% Indian
mongooses, thus conﬁrming the major role of this species as nat-
ural reservoir of B. henselae.
1.17. Parallel SESSION 11bis: Orienta tsutsugamushi
Jason A. Carlyon (USA) made a nice presentation on the role of
ankyrin repeat-containing effectors as modulators of host cell
processes and described the numerous experiments that his team
performed to gain insight into this complex phenomenon. He
notably described the importance of the NF-kB pathway and how
Ank 1 and Ank6 inhibit NF-kB nuclear accumulation [37].
In the next presentation, Paul Newton (United Kingdom) pre-
sented a clinical trial of doxycycline and azithromycin in murine
typhus therapy. The trial involved 216 patients withmurine typhus.
Three regimens were tried: doxycycline 7 days, doxycycline 3 days
and azithromycin. A high level of treatment failure was seen in
patients treated with azithromycin and fever clearance was ob-
tained in a larger delay. As a conclusion, Pr Newton recommended
that azithromycin should not be used for the treatment of un-
complicated murine typhus. He also questioned the management
of pregnant women and patients with severe infections.
As part of short presentations, Daniel Paris (Switzerland)
described the burden of scrub typhus in Asia through an extensive
review of the literature. He studied the data of more than 143,000
cases. Dr Paris also insisted that scrub typhus is a very neglected
disease, not even included in the Global Burden of neglected dis-
eases. In Asia, the seroprevalence for scrub typhus ranges from 9 to
28%, and an increased incidence has been reported in several coun-
tries. Ivo Elliott (United Kingdom) then described the ecology of
scrub typhus and the evolution of diagnostic tools over time. He also
insisted on the partial knowledge of mite vectors and various other
aspects of the disease, urging for additional work. Christian Keller
(Germany) reported data on a new drug active on O. tsutsugamushi,
highlighting the estimated number of onemillion cases annually. The
4 antibiotic classes active are tetracyclines, azithromycin, chloram-
phenicol and rifampicin. A newmolecule, corallopyronin A acting on
RNA polymerase may be valuable for scrub typhus. An animal model
in BALB/c mice conﬁrmed the good activity of CorA on O. tsutsuga-
mushi by curing all animals within 2 days. No human assays have
been made to date. Manisha Biswal (India) reported the genetic
diversity of O. tsutsugamushi in northern India. Scrub typhus is
prevalent in 22/28 Indian states. In a series of 228 patients, Dr Biswal
observed a mortality of 12.8%. Using genotyping, she observed 4
genotypes, the most important being Karp-like, notably Boryong. No
Kato strains were detected. The last speaker of session 11biswasKyle
Rodino (USA) who described the modulation of endoplasmic retic-
ulum (ER) by O. tsutsugamushi. By inducing an ER stress, he could
observe a beneﬁcial effect on O. tsutsugamushi growth. However, the
addition of amino acids restored the growth defect. Therefore, O.
tsutsugamushi is able to modulate ER-associated degradation.
Fig. 1. All participants of the ESCCAR congress gathered at the “Vieux-Port” of Marseille for the gala dinner.
Table 1
New composition of the ESCCAR board, 2017 to 2020.
Task in the ESCCAR board Name Town (Country) Speciality
Presidenta Gilbert Greub Lausanne (Switzerland) Chlamydia and chlamydia-related bacteria
Vice-presidentb Aranzazu Portillo Logrono (Spain) Mainly Rickettsia
Past-President Pierre-Edouard Fournier Marseille (France) Mainly Rickettsia & Bartonella
Secretary Idir Bitam Alger (Algeria) Entomology and Rickettsia
Board member Chantal Bleekers Nijmegen (The Netherlands) Coxiella & Q fever
Board member Mirja Puoallakainen Helsinki (Finland) Chlamydia pneumoniae
Board member Adam Polkinghorne Brisbane (Australia) Chlamydial genomics and veterinary microbiology
Board member Beatte Heinrichfreise Bonn (Germany) Chlamydial biology
a The president, Mr. Prof Gilbert Greub will organize the 2020 ASR-ESCCAR meeting in Lausanne (Switzerland).
b The vice-president, Mrs. Dr Aranzazu Portillo will organize the 2023 meeting in Logrono (Spain).
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The ﬁnal session of the congress was opened by Stephen Graves
(Australia) who described a new vaccine for Q fever. As a back-
ground, he described an outbreak of 24 Q fever cases including a
patient who was vaccinated, suggesting that the degree of protec-
tion provided by the vaccine might not be optimal. Consequently, a
new vaccine was developed from C. burnetii strain Meredith AuQ
60. When tested in Guinea pigs, vaccinated animals did not develop
fever. When administered to goats, the vaccine elicited the pro-
duction of antibodies but no side effects except a local transient
erythema at the injection site. So this new vaccine appears very
promising and will be further developed and tested.
Then, Alice Cross (United Kingdom) described the UK situation
where no Q fever vaccine is available. Her project was to develop a
C. burnetii LPS-based vaccine. She described the ﬁrst steps of her
strategy to synthesize in vitro the O-antigen that would be used as
vaccine antigen. Elodie Rousset (France) described a French
attempt at harmonizing the PCR-based diagnosis of Q fever in ru-
minants. Ten laboratories were involved in this study and seven
qPCR methods tested. An assay was ﬁnally selected and its char-
acteristics (reproducibility, sensitivity, speciﬁcity, positive and
negative predictive values) assessed. Then, Elsa Jourdain (France)
described the use of swab cloths to detect C. burnetii contaminating
ruminant herds. Ten French departments took part in the study.
Sterile swab cloths were mailed to farmers. Swab cloths were sent
back to INRA where DNA extraction and PCR were performed. A
total of 109 samples were obtained, 52 of which (48%) were PCR-
positive for C. burnetii. Bacterial loads were high, up to 10P8 bac-
teria. These results validated this method for environmental sur-
veillance. In the last presentation of the congress, DimitiosFrangoulidis (Germany) described the genomic comparison of 2 C.
burnetii strains, virulent phase I RSA 493 and phase II RSA 439. Very
few differences were identiﬁed between strains. Among those, the
wecA gene was lost by the avirulent strain.2. Conclusion
The ASR-ESCCARmeeting was as shown by the diversity and the
quality of the talks described above a very fruitful scientiﬁc event.
In addition, there were many opportunities to network during the
breaks, in front of themany posters that were presented and during
the social events. The latter included (i) on Monday evening, a Jazz
& Blues concert given in the Toga amphitheater by a local group
from Marseille mainly composed of scientists and followed by an
apero served in the hall of the Faculty of Medicine at La Timone, as
well as (ii) a gala dinner held in Fort Ganteaume, in a beautiful
location in Marseille Vieux Port (Fig. 1). At the end of the meeting,
the question that all participants were asking themselves was
“when and where will be the next ASR-ESCCAR meeting” since no
one would miss such a unique meeting in terms of science and
networking. The answer was brought by the election of the new
ESCCAR committee held on Wednesday 21st June. Prof. Greub was
elected President and will thus organize with the other board
members (Table 1) the next triennial international ASR-ESCCAR
meeting on intracellular bacteria in Lausanne from 31th August to
3rd September 2020. Looking forward to see all of you there.Conﬂict of interest
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